The candidate will play a critical role in building and leading a high-performing team that accelerates AstraZeneca’s emerging Cell Therapy modalities portfolio
Job Summary
The candidate will play a critical role in building and leading a high-performing team that accelerates AstraZeneca’s emerging Cell Therapy modalities portfolio.
You will design, execute, and optimize scalable Lentiviral Vector (LVV) down stream purification processes with a primary focus on clinical and commercial scales.
The annual base pay for this position ranges from $ 108,473.60 - $162,710.40.
Matching Summary
The candidate will play a critical role in building and leading a high-performing team that accelerates AstraZeneca’s emerging Cell Therapy modalities portfolio.
Salary
Base: $108,473.60 - $162,710.40; Bonus/Equity: Short-term incentive bonus opportunity, equity-based long-term incentive program; Benefits: Qualified retirement program (401(k) plan), paid vacation and holidays, paid leaves, health benefits
Skills & Requirements
Must-have
Viral Vector Downstream Purification
Scalable Lentiviral Vector Processes
Process Characterization and Scale-Up
cGMP and Quality Systems
Cross-functional Collaboration
Nice-to-have
Next-generation purification technologies
PAT/digital tools for process monitoring
Innovation and continuous improvement
Key Requirements
Ph.D. or M.S. or B.S. with relevant industry experience
1+ years industry experience (Ph.D.)
4+ years industry experience (M.S.)
5+ years industry experience (B.S.)
Hands-on downstream process development experience
Familiarity with clinical/commercial scale considerations